Alexander Labrunerie & Co’s Merck MRK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$454K Buy
3,530
+14
+0.4% +$1.64K 0.16% 70
2026
Q1
$423K Buy
3,516
+4
+0.1% +$462 0.16% 74
2025
Q4
$370K Buy
3,512
+14
+0.4% +$1.31K 0.13% 78
2025
Q3
$294K Sell
3,498
-226
-6% -$18.6K 0.11% 87
2025
Q2
$295K Buy
3,724
+230
+7% +$18.3K 0.12% 81
2025
Q1
$314K Buy
3,494
+4
+0.1% +$373 0.14% 80
2024
Q4
$347K Buy
3,490
+3
+0.1% +$309 0.15% 73
2024
Q3
$396K Buy
3,487
+3
+0.1% +$356 0.18% 64
2024
Q2
$431K Sell
3,484
-121
-3% -$15.6K 0.23% 55
2024
Q1
$476K Buy
+3,605
New +$444K 0.27% 56

Other funds holding MRK

Alexander Labrunerie & Co's MRK Position: Q2 2026 in Review

Alexander Labrunerie & Co increased its Merck (MRK) stake by 0.4% in Q2 2026, buying an estimated $1.64K and bringing the position to 3,530 shares worth $454K. The position accounts for 0.16% of the portfolio, ranked #70.

Alexander Labrunerie & Co first reported a position in MRK in Q1 2024 and has held it in 10 quarters since. The position peaked at $476K in Q1 2024. 3,852 funds tracked by Wall St. Rank hold MRK as of Q2 2026.

  • Alexander Labrunerie & Co held 3,530 shares of Merck worth $454K as of Q2 2026.
  • Alexander Labrunerie & Co bought 14 Merck shares in Q2 2026, an estimated $1.64K.
  • Merck made up 0.16% of Alexander Labrunerie & Co's portfolio in Q2 2026, its #70 holding.
  • Alexander Labrunerie & Co first reported a position in Merck in Q1 2024 and has held it in 10 quarters since.
  • Alexander Labrunerie & Co's Merck position peaked at $476K in Q1 2024.
  • 3,852 funds tracked by Wall St. Rank held Merck as of Q2 2026.

Based on Alexander Labrunerie & Co's 13F filing for Q2 2026, filed 3 Aug 2026.